Talis Biomedical Corp Insider Trading Activity
Every SEC Form 4 insider transaction reported for Talis Biomedical Corp (TLIS), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are TLIS insiders buying or selling?
Talis Biomedical Corp insiders reported no open-market purchases or sales in the last 12 months. Since February 2021, Trabud has recorded 15 Form 4 filings for TLIS: 14 buys ($106.7M) and 1 sells ($210.7K).
Source: SEC EDGAR Form 4
Key Statistics (February 2021 – Sep 9, 2024)
Total Form 4 filings
15
SEC EDGAR
Insider filers
9
Insider buys (14)
$106.7M
Insider sells (1)
$210.7K
Insider sentiment
Net buyingNet insider flow of $106.5M in net buying since February 2021.
Recent TLIS insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 30.1K | $1.47 | $44.2K | SEC ↗ |
| Sep 5, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 500 | $4.00 | $2.0K | SEC ↗ |
| Sep 5, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 151 | $4.25 | $641.75 | SEC ↗ |
| Aug 28, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 14.4K | $3.90 | $56.1K | SEC ↗ |
| Nov 19, 2021 | Julian Baker | Director, 10% Owner | Purchase | 50.0K | $4.37 | $218.3K | SEC ↗ |
| Aug 17, 2021 | Ramesh Ramakrishnan | Other | Sale | 27.5K | $7.66 | $210.7K | SEC ↗ |
| May 18, 2021 | Randal W. Scott | Director | Purchase | 20.0K | $10.13 | $202.7K | SEC ↗ |
| Feb 19, 2021 | Kimberly J Popovits | Director | Purchase | 5.3K | $16.00 | $84.8K | SEC ↗ |
| Feb 19, 2021 | Randal W. Scott | Director | Purchase | 312.5K | $16.00 | $5.0M | SEC ↗ |
| Feb 19, 2021 | Felix Baker | Director, 10% Owner | Purchase | 6.3M | $16.00 | $100.0M | SEC ↗ |
| Feb 19, 2021 | Ramesh Ramakrishnan | Sr. Vice President, R&D | Purchase | 1.0K | $16.00 | $16.0K | SEC ↗ |
| Feb 19, 2021 | Matthew L. Posard | Director | Purchase | 62.5K | $16.00 | $1.0M | SEC ↗ |
| Feb 19, 2021 | John Roger Moody Jr | Chief Financial Officer | Purchase | 1.7K | $16.00 | $27.2K | SEC ↗ |
| Feb 19, 2021 | Douglas Liu | Sr. Vice President, Operations | Purchase | 4.0K | $16.00 | $64.0K | SEC ↗ |
| Feb 19, 2021 | Karen E. Flick | Chief of Staff, Sr. VP, Legal | Purchase | 2.0K | $16.00 | $32.0K | SEC ↗ |
Showing the 15 most recent of 15 Form 4 filings for Talis Biomedical Corp.
Most active TLIS insiders
- Braden Michael Leonard4 filings
- Felix Baker2 filings
- Ramesh Ramakrishnan2 filings
- Randal W. Scott2 filings
- Douglas Liu1 filing
Ask anything about TLIS insider activity
Use Trabud's AI agent to query Talis Biomedical Corp's Form 4 history in plain English — "Show me TLIS CEO purchases this year" or compare it against any other ticker.
Open the AI agentTLIS insider trading FAQ
Are Talis Biomedical Corp insiders buying or selling?
Talis Biomedical Corp insiders reported no open-market purchases or sales in the last 12 months. Since February 2021, Trabud has recorded 15 Form 4 filings for TLIS: 14 buys ($106.7M) and 1 sells ($210.7K). Over the full record that is net buying of $106.5M.
How many insiders trade TLIS stock?
9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Talis Biomedical Corp. The most recent filing was accepted on Sep 9, 2024.
Where does Trabud get TLIS insider trading data?
All TLIS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.